Rene Duregger, MD
Child & Adolescent Psychiatry · Mason City, IANPI 1245436765
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $356 and has fallen 95.6% since, to $16 in 2025.
Across 64 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$181
- AbbVie$159
- Johnson & Johnson$102
- Lundbeck LLC$69
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$64
- Axsome Therapeutics, Inc.$57
- plus $433 from 12 others
What the payments were for
- Food & beverage$1,065100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $181 |
| AbbVie(2 entities) | 9 | $159 |
| Johnson & Johnson | 7 | $102 |
| Lundbeck LLC | 4 | $69 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $64 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Supernus Pharmaceuticals, Inc. | 3 | $56 |
| Tris Pharma Inc | 3 | $50 |
| Ironshore Pharmaceuticals Inc. | 3 | $48 |
| Alkermes, Inc. | 3 | $48 |
| Neurocrine Biosciences, Inc. | 3 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| OWP Pharmaceuticals, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Vertical Pharmaceuticals, LLC | 2 | $25 |
| Neos Therapeutics, LP | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
How this compares
$1,065 in reported general payments places this provider in the 65th percentile of 20 child & adolescent psychiatry providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 23 | $26,464 |
| TrintellixVortioxetine Hydrobromide | 11 | $5,131 |
| Aripiprazole | 17 | $1,153 |
| Duloxetine Hcl | 105 | $984 |
| Lurasidone Hcl | 21 | $843 |
| Bupropion XlBupropion Hcl | 50 | $648 |
| Quetiapine Fumarate | 52 | $492 |
| Lamotrigine | 48 | $451 |
| Hydroxyzine Hcl | 15 | $335 |
| Prazosin Hcl | 29 | $279 |
| Buspirone Hcl | 45 | $278 |
| Fluoxetine Hcl | 45 | $273 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 32 | $261 |
| Trazodone Hcl | 65 | $241 |
| Benztropine Mesylate | 25 | $238 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $159 | $26,46423 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $27 | $5,13111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 20 child & adolescent psychiatry providers in Iowa.
Other child & adolescent psychiatry in Mason City
- Daniel GilletteSioux City$48K
- Christopher OkiishiNorth Liberty$13K
- Patrick ChauSioux City$10K
- Flynn McCulloughSioux City$6K
- Donner DewdneyWest Des Moines$2K
- Leenu MishraDes Moines$1K
- Ivan Delgado RamosAtlantic$526
- Anne KolarIowa City$434
- Sasha KhosraviDes Moines$314
- Thomas HopkinsWest Des Moines$254
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.